A股異動 | ST八菱(002592.SZ)漲停 擬處置控股子公司弘潤天源51%股權
格隆匯12月31日丨ST八菱(002592.SZ)漲停,封單不足一萬手,現報3.37元,暫成交1713萬元,最新總市值9億元。ST八菱昨晚公佈,擬處置控股子公司北京弘潤天源基因生物技術有限公司51%股權,股權處置意向尚處於籌劃階段。公司於2019年作價9.08億元收購弘潤天源51%股權,併購後,弘潤天源經營狀況持續惡化,經營業績遠達不到預期,兩年累計僅實現承諾業績的3.08%。為降低公司經營風險,防止虧損進一步擴大,公司擬對持有的弘潤天源51%股權進行處置。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.